These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 22111543

  • 1. Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer.
    Machens A, Frank-Raue K, Lorenz K, Rondot S, Raue F, Dralle H.
    Clin Endocrinol (Oxf); 2012 May; 76(5):691-7. PubMed ID: 22111543
    [Abstract] [Full Text] [Related]

  • 2. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
    Siqueira DR, Romitti M, da Rocha AP, Ceolin L, Meotti C, Estivalet A, Puñales MK, Maia AL.
    Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
    [Abstract] [Full Text] [Related]

  • 3. [RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients].
    Severskaia NV, Saenko VA, Il'in AA, Chebotareva IV, Rumiantsev PO, Isaev PA, Medvedev VS, Iasmita S.
    Mol Biol (Mosk); 2006 Dec; 40(3):425-35. PubMed ID: 16813162
    [Abstract] [Full Text] [Related]

  • 4. [G691S, L769L and S836S ret proto-oncogene polymorphisms are not associated with higher risk to sporadic medullary thyroid carcinoma in Chilean patients].
    Wohllk G N, Soto C E, Bravo A M, Becker C P.
    Rev Med Chil; 2005 Apr; 133(4):397-402. PubMed ID: 15953945
    [Abstract] [Full Text] [Related]

  • 5. Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness.
    Ceolin L, Siqueira DR, Ferreira CV, Romitti M, Maia SC, Leiria L, Crispim D, Ashton-Prolla P, Maia AL.
    Eur J Endocrinol; 2012 May; 166(5):847-54. PubMed ID: 22345297
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma?
    Baumgartner-Parzer SM, Lang R, Wagner L, Heinze G, Niederle B, Kaserer K, Waldhäusl W, Vierhapper H.
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6232-6. PubMed ID: 16118333
    [Abstract] [Full Text] [Related]

  • 7. RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population.
    Elisei R, Cosci B, Romei C, Bottici V, Sculli M, Lari R, Barale R, Pacini F, Pinchera A.
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3579-84. PubMed ID: 15240649
    [Abstract] [Full Text] [Related]

  • 8. Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.
    Gursoy A, Erdogan MF, Erdogan G.
    J Endocrinol Invest; 2006 Nov; 29(10):858-62. PubMed ID: 17185892
    [Abstract] [Full Text] [Related]

  • 9. Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer.
    Khan MS, Pandith AA, Iqbal M, Naykoo NA, Khan SH, Rather TA, Mudassar S.
    J Cell Biochem; 2015 Aug; 116(8):1712-8. PubMed ID: 25736215
    [Abstract] [Full Text] [Related]

  • 10. Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma.
    Fernández RM, Peciña A, Antiñolo G, Navarro E, Borrego S.
    Thyroid; 2006 Apr; 16(4):411-7. PubMed ID: 16646689
    [Abstract] [Full Text] [Related]

  • 11. Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
    Cardot-Bauters C, Leteurtre E, Leclerc L, Vantyghem MC, Do Cao C, Wemeau JL, d'Herbomez M, Carnaille B, Barbu V, Pinson S, Pigny P, Groupe d'Etude des Tumeurs Endocrines (GTE).
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):506-10. PubMed ID: 18331611
    [Abstract] [Full Text] [Related]

  • 12. Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.
    Borrello MG, Aiello A, Peissel B, Rizzetti MG, Mondellini P, Degl'Innocenti D, Catalano V, Gobbo M, Collini P, Bongarzone I, Pierotti MA, Greco A, Seregni E.
    Endocr Relat Cancer; 2011 Aug; 18(4):519-27. PubMed ID: 21690267
    [Abstract] [Full Text] [Related]

  • 13. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
    Lebeault M, Pinson S, Guillaud-Bataille M, Gimenez-Roqueplo AP, Carrie A, Barbu V, Pigny P, Bezieau S, Rey JM, Delvincourt C, Giraud S, Veyrat-Durebex C, Saulnier P, Bouzamondo N, Chabbert M, Blin J, Mohamed A, Romanet P, Borson-Chazot F, Rohmer V, Barlier A, Mirebeau-Prunier D.
    Thyroid; 2017 Dec; 27(12):1511-1522. PubMed ID: 28946813
    [Abstract] [Full Text] [Related]

  • 14. Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation.
    Shifrin AL, Ogilvie JB, Stang MT, Fay AM, Kuo YH, Matulewicz T, Xenachis CZ, Vernick JJ.
    Surgery; 2010 Dec; 148(6):1274-80; discussion 1280-1. PubMed ID: 21134561
    [Abstract] [Full Text] [Related]

  • 15. [Genetic polymorphisms: implications in the pathogenesis of medullary thyroid carcinoma].
    Rocha AP, Magalhães PK, Maia AL, Maciel LM.
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):723-30. PubMed ID: 17891235
    [Abstract] [Full Text] [Related]

  • 16. Quantitative assessment of the association between L769L and S836S polymorphisms at RET gene and medullary thyroid carcinoma risk.
    Zhang Y, Wang S, Chen X, Huang S, Li J.
    Tumour Biol; 2014 Jul; 35(7):6641-7. PubMed ID: 24699996
    [Abstract] [Full Text] [Related]

  • 17. Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.
    Ruiz A, Antiñolo G, Fernández RM, Eng C, Marcos I, Borrego S.
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):399-402. PubMed ID: 11589684
    [Abstract] [Full Text] [Related]

  • 18. Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.
    Figlioli G, Landi S, Romei C, Elisei R, Gemignani F.
    Mutat Res; 2013 Sep; 752(1):36-44. PubMed ID: 23059849
    [Abstract] [Full Text] [Related]

  • 19. RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series.
    Fugazzola L, Muzza M, Mian C, Cordella D, Barollo S, Alberti L, Cirello V, Dazzi D, Girelli ME, Opocher G, Beck-Peccoz P, Persani L.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):418-25. PubMed ID: 18284634
    [Abstract] [Full Text] [Related]

  • 20. Effect of 3'UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma.
    Ceolin L, Romitti M, Siqueira DR, Vaz Ferreira C, Oliboni Scapineli J, Assis-Brazil B, Vieira Maximiano R, Dias Amarante T, de Souza Nunes MC, Weber G, Maia AL.
    PLoS One; 2016 Sep; 11(2):e0147840. PubMed ID: 26829565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.